Publikationen, an denen er mitarbeitet Luis Felipe Callado Hernando (8)
2024
-
Effect of antipsychotic drugs on group II metabotropic glutamate receptor expression and epigenetic control in postmortem brains of schizophrenia subjects
Translational Psychiatry, Vol. 14, Núm. 1
2021
-
Di-aryl guanidinium derivatives: Towards improved α2-Adrenergic affinity and antagonist activity
European Journal of Medicinal Chemistry, Vol. 209
-
Differential brain ADRA2A and ADRA2C gene expression and epigenetic regulation in schizophrenia. Effect of antipsychotic drug treatment
Translational Psychiatry, Vol. 11, Núm. 1
-
Opposite alterations of 5HT2A receptor brain density in subjects with schizophrenia: relevance of radiotracers pharmacological profile
Translational Psychiatry, Vol. 11, Núm. 1
-
Subcellular specificity of cannabinoid effects in striatonigral circuits
Neuron, Vol. 109, Núm. 9, pp. 1513-1526.e11
2019
-
Serotonin 5-HT2A receptor expression and functionality in postmortem frontal cortex of subjects with schizophrenia: Selective biased agonism via Gαi1-proteins
European Neuropsychopharmacology, Vol. 29, Núm. 12, pp. 1453-1463
2016
-
Substituted conformationally restricted guanidine derivatives: Probing the α2-adrenoceptors’ binding pocket
European Journal of Medicinal Chemistry, Vol. 123, pp. 48-57
2014
-
Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: Effect of antidepressant treatment
Neuropharmacology, Vol. 86, pp. 311-318